INVE vs JNJ · rev $13.1M vs P/E 17, rev $49.37B
Identiv Inc (INVE) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Identiv Inc (INVE) is a building products & equipment company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported INVE revenue for 2026-06-30 was $13.1M. Net income was -$8.1M. Revenue was up 76.6% from 2026-03-31 to 2026-06-30. INVE currently screens at market cap $96.3M.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
INVE currently screens at market cap $96.3M. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the INVE and JNJ stock pages for the full models.
Not investment advice.